News & Updates
Filter by Specialty:
High-dose iberdomide shows promise in phase II SLE trial
In a phase II trial evaluating three doses of the high-affinity cereblon modulator iberdomide, the 0.45-mg dose demonstrated superiority over placebo for individuals with active, moderate-to-severe systemic lupus erythematosus (SLE).
High-dose iberdomide shows promise in phase II SLE trial
07 Jun 2022
H. pylori eradication suppresses long-term gastric cancer risk
Helicobacter pylori eradication treatment leads to large reductions in the risk of gastric cancer and lower rates of associated deaths over 10 years of follow-up, according to a recent meta-analysis.
H. pylori eradication suppresses long-term gastric cancer risk
07 Jun 2022
Transvaginal sonography accepted by women with PMB if high endometrial Ca detection rate
A recent cross-sectional questionnaire study has shown that women with postmenopausal bleeding (PMB) would select transvaginal sonography to measure endometrial thickness (TVS-ET) over gold-standard hysteroscopy with biopsy if TVS-ET achieved a median endometrial cancer detection rate of 95.0 percent.
Transvaginal sonography accepted by women with PMB if high endometrial Ca detection rate
07 Jun 2022
Tenapanor improves symptoms in patients with IBS-C
Treatment with tenapanor improves symptoms in patients with irritable bowel syndrome with constipation (IBS-C) as early as week 1 of treatment, according to two phase III studies presented at DDW 2022.
Tenapanor improves symptoms in patients with IBS-C
07 Jun 2022
High depressive symptoms at multiple timepoints carry elevated stroke risk
Among individuals who have undergone repeated assessments for depression, the presence of high symptoms at multiple timepoints raises the risk of developing stroke, according to a study.